TUMORICIDAL AND IMMUNOMODULATORY ACTIVITIES OF DRUGS AND IMPLICATIONS FOR THERAPY OF MICE BEARING A LATE STAGE MOPC-315-PLASMACYTOMA

被引：10

作者：

BERKO, R

SEISSMAN, K

COLVIN, M

BOCIAN, RC

BENEFRAIM, S

DRAY, S

机构：

[1] UNIV ILLINOIS,DEPT MICROBIOL & IMMUNOL,CHICAGO,IL 60680

[2] JOHNS HOPKINS UNIV,SCH MED,CTR ONCOL,BALTIMORE,MD 21205

来源：

INTERNATIONAL JOURNAL OF IMMUNOPHARMACOLOGY | 1988年 / 10卷 / 07期

关键词：

D O I：

10.1016/0192-0561(88)90006-9

中图分类号：

R392 [医学免疫学]; Q939.91 [免疫学];

学科分类号：

100102 ;

摘要：

引用

页码：825 / 834

页数：10

共 25 条

[1]

ADAMSON RH, 1965, ARCH INT PHARMACOD T, V153, P87

[2]

BENEFRAIM S, 1983, CANCER IMMUNOL IMMUN, V15, P101

[3]

BOCIAN RC, 1984, CANCER IMMUNOL IMMUN, V18, P41

[4]

BOCIAN RC, 1985, CANCER IMMUNOL IMMUN, V20, P61

[5]

COLVIN M, 1976, CANCER RES, V36, P1121

[6] DECOMPOSITION OF BCNU (1,3-BIS(2-CHLOROETHYL)-1-NITROSOUREA) IN AQUEOUS-SOLUTION [J].

COLVIN, M ;

COWENS, JW ;

BRUNDRETT, RB ;

KRAMER, BS ;

LUDLUM, DB .

BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1974, 60 (02) :515-520

[7]

CONNORS TA, 1976, BIOCH PHARM, V25, P993

[8]

DOMEYER BE, 1980, CANCER RES, V40, P174

[9]

EVANS TL, 1982, CANCER CHEMOTH PHARM, V8, P175

[10]

FRIEDMAN OM, 1979, ADV CANC CHEMOTHERAP, P143

← 1 2 3 →